Queens
Astoria
37-15 23rd Ave, Astoria, NY 11105
A western Queens option for patients who want easier access than crossing into Manhattan for every monitored treatment day.
View location detailsSpravato and Medicaid
Spravato is the FDA-approved esketamine nasal spray treatment pathway available through certified healthcare settings. Nao Medical reviews Medicaid coverage for eligible patients in NYC and Long Island.
Multi-location Spravato access across NYC and Long Island, with care-manager support, Medicaid access, and clinic options that account for repeated monitored visits.
Esketamine nasal spray refers to Spravato, a prescription treatment administered under supervision in a certified healthcare setting. It is not a take-home nasal spray, and patients are monitored after dosing before leaving the clinic.
Medicaid coverage depends on eligibility, active benefits, diagnosis, documentation, and prior authorization rules. The care team can review Medicaid or Medicaid Managed Care coverage and explain what information may be needed before treatment can be scheduled.
Clinical references reviewed: SPRAVATO REMS and the FDA prescribing information. Last reviewed May 2026. This information does not replace a clinical evaluation.
Queens
37-15 23rd Ave, Astoria, NY 11105
A western Queens option for patients who want easier access than crossing into Manhattan for every monitored treatment day.
View location detailsBronx
2063A Bartow Ave, Bronx, NY 10475
A Bronx access point for patients who want local Spravato care without leaving the borough.
View location detailsLong Island
232 W Old Country Rd, Hicksville, NY 11801
A central Nassau option for patients who need consistent follow-up, prior auth support, and a shorter commute.
View location detailsQueens
90-18 Sutphin Blvd, Jamaica, NY 11435
A southeast Queens location that helps patients stay on schedule for repeated monitored sessions.
View location detailsQueens
30-07 36th Ave, Astoria, NY 11106
A western Queens access point for patients balancing treatment days with work, home, or Manhattan commutes.
View location detailsLong Island
135 Mineola Blvd, Mineola, NY 11501
A Long Island access point for patients who want strong benefits support and reliable treatment coordination.
View location detailsManhattan
259 1st Ave, New York, NY 10003
A Manhattan Spravato access point for East Village, Gramercy, Kips Bay, and nearby neighborhoods.
View location detailsBrooklyn
308 Graham Ave, Brooklyn, NY 11211
The lead Brooklyn Spravato location for patients who want local access and ongoing psychiatric support.
View location detailsAccepted plans can vary by eligibility and authorization rules. This list reflects the insurance access Nao Medical can review for eligible Spravato patients, including Medicaid, Medicare, Medicare Advantage, and commercial coverage options.
Spravato is the branded esketamine nasal spray treatment used under REMS requirements in certified healthcare settings.
Medicaid coverage can be reviewed for eligible patients. Coverage depends on diagnosis, documentation, benefits, and authorization.
No. Spravato is not dispensed directly to patients for home use.
Nao Medical reviews Medicaid and Medicaid Managed Care coverage for eligible Spravato patients.